HUNTINGTON, N.Y., Jan. 22, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces a financial and strategic investment from 5 Horizons Capital. Horizon, as the lead investor for the Phase 2 clinical...
Hence then, the article about sen jam pharmaceutical secures financial and strategic investment from 5 horizons capital to advance sjp 001 clinical trial with novotech was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech )
Also on site :
- Nigerian general killed in Islamic State attack
- The Oil Shock Is Worse Than You Think
- Kremlin explains Easter ceasefire